Diploma (LON:DPLM - Get Free Report) had its price target hoisted by equities research analysts at Jefferies Financial Group from GBX 4,500 to GBX 5,200 in a report issued on Thursday, MarketBeat.com reports. The firm currently has a "hold" rating on the stock. Jefferies Financial Group's target price would indicate a potential downside of 4.61% from the stock's current price.
Several other brokerages have also issued reports on DPLM. Berenberg Bank reiterated a "buy" rating and set a GBX 5,750 price objective on shares of Diploma in a report on Tuesday, September 2nd. Shore Capital reiterated a "hold" rating and issued a GBX 5,100 price objective on shares of Diploma in a research note on Thursday, July 17th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and issued a GBX 4,440 price objective on shares of Diploma in a research note on Wednesday, August 6th. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Diploma has an average rating of "Hold" and a consensus price target of GBX 5,238.
Check Out Our Latest Report on Diploma
Diploma Stock Down 0.9%
Shares of DPLM traded down GBX 48.91 during mid-day trading on Thursday, reaching GBX 5,451.10. The company's stock had a trading volume of 230,669 shares, compared to its average volume of 467,316. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. Diploma has a 1 year low of GBX 3,532 and a 1 year high of GBX 5,625. The business has a fifty day moving average of GBX 5,299.66 and a 200 day moving average of GBX 4,632.25. The company has a market cap of £7.31 billion, a price-to-earnings ratio of 4,385.43, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More

Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.